Interojo Co

Interojo Co Financing Cash Flow

The Net Financing Cash Flow of Interojo Co (119610.KQ) as of Nov 20, 2026 is 7.89 B KRW. In the previous year, Net Financing Cash Flow was 4.45 B KRW — a change of 77.28% (higher).

Financing Cash Flow

7.89 BKRW

YoY

77.28%

Last updated:

Net Financing Cash Flow of Interojo Co is 2022 7.89 B KRW. Net Financing Cash Flow of Interojo Co was 2021 4.45 B KRW. It decreases by 77.28% higher compared to the previous year.

The Interojo Co Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2015
-885.18 M KRW
Jan 1, 2016
-6.02 B KRW
Jan 1, 2017
-9.64 B KRW
Jan 1, 2018
9.23 B KRW
Jan 1, 2019
9.75 B KRW
Jan 1, 2020
2.53 B KRW
Jan 1, 2021
4.45 B KRW
Jan 1, 2022
7.89 B KRW
The Interojo Co Financing Cash Flow history
YEARFinancing Cash FlowYoY
7.89 BKRW+77.28%
4.45 BKRW+75.88%
2.53 BKRW-74.04%
9.75 BKRW+5.56%
9.23 BKRW-195.84%
-9.64 BKRW+59.93%
-6.02 BKRW+580.61%
-885.18 MKRW-225.07%
707.76 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co Stock analysis

What does Interojo Co do? Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services. Interojo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Interojo Co stock

Net Financing Cash Flow of Interojo Co is 7.89 B KRW in 2022.

Net Financing Cash Flow of Interojo Co changed from 4.45 B KRW to 7.89 B KRW, representing a 77.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Interojo Co since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Interojo Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Interojo Co

All Key Metrics — Interojo Co